The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Revisiting: What pooling buys you and what it destroys

This is a generated summary. It shows the 9 most-liked posts from a topic of 108, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
JW
journalclub_wrenTL3Regular15 Apr 2026#1

On the subject in the title: Revisiting: What pooling buys you and what it destroys Working notes rather than a conclusion.

Session topic: PIONEER 6 (N Engl J Med, 2019). Please read it before posting; the discussion is much better when everyone has.

The question I would like us to start with is what the trial set out to estimate, rather than what it found. Once that is on the table we can talk about whether the design could have answered it, and only then about the numbers.

Specific things I would like covered: the population and how far it generalises, how discontinuation was handled, whether the comparator was a fair one, and what the absolute rather than relative effect looks like.

I will summarise at the end and the summary will feed the relevant digest page.

30 likes 3mo
ZA
z.adeyemiTL2 Moderator18 Apr 2026 · edited#2

Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline risk is specified. More interpretable than pooled relative effects.

31 likes 3mo
IG
i.grimaldiTL2 Moderator Solution22 Apr 2026#4

Worth separating two things that post #2 runs together.

Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too broad, apples and oranges get pooled. If they are too narrow, the meta-analysis answers a overly specific question.

10 likes 3mo
KB
k.brandl_deTL3Translator · DE29 Apr 2026 · edited#9

This follows post #6 rather than contradicting it.

Publication bias: what did not get published? Small studies with negative results are less likely to be published than large studies with positive results. A forest plot with only large studies on the positive end is a red flag for unpublished small negative studies.

30 likes 3mo
VB
v.bhattacharyaTL2 Moderator5 May 2026#14

This follows post #11 rather than contradicting it.

When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents nothing in particular. Reading the individual studies is more useful than reading the pooled estimate.

30 likes 3mo
CO
c.ostergaardTL2 Moderator11 May 2026#19

Worth separating two things that post #15 runs together.

Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too broad, apples and oranges get pooled. If they are too narrow, the meta-analysis answers a overly specific question.

29 likes 3mo
CR
c.rasmussenTL2 Moderator5 Jun 2026#44

Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is asymmetrical.

33 likes 2mo
CL
coldchain_liuTL3Regular15 Jun 2026#56
c.bakker, post #42: Coming back to post #40, because the follow-up matters more than the original answer. Publication bias: what did not get published? Small studies with negative results are less likely to be published than large studies with positive results. A forest plot with only large studies on the positive end is a red flag for unpublished small… Go to post

post #55 is right about the mechanism and I think understates the practical bit.

Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be stated and justified.

31 likes in reply to #42 1mo
BT
baseline_tableTL2Member28 Jun 2026#71

Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be stated and justified.

33 likes 30d

Read the full topic (108 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Second pass at: When a network meta-analysis is defensible and when it is not
Posting this under the heading it deserves: Second pass at: When a network meta-analysis is defensible and when it is not Everything below is what sits behind that. Comparing STEP 8 ( JAMA , 2022) with LEADER…
LSOID 2 2.8k 21mo
Publication bias detection and its low power
On the subject in the title: Publication bias detection and its low power Working notes rather than a conclusion. I have seen SURMOUNT-1 ( N Engl J Med , 2022) cited in support of a claim I do not think it…
MAZLKK 2 3.2k 1d
Random versus fixed effects: choosing rather than defaulting — a second dataset
On the subject in the title: Random versus fixed effects: choosing rather than defaulting — a second dataset Working notes rather than a conclusion. Session topic: STEP 2 ( Lancet , 2021). Please read it…
NCJVSDBSEF+95 106 20k 17mo
Risk-of-bias tools and the judgement they conceal
Risk-of-bias tools and the judgement they conceal Writing it up because I had to work it out twice and would rather nobody else did. I have seen STEP 1 ( N Engl J Med , 2021) cited in support of a claim I do…
KBHALPMECI+8 12 21k 11mo
Random versus fixed effects: choosing rather than defaulting
Random versus fixed effects: choosing rather than defaulting — setting out what I have, and where I think it stops being reliable. Session topic: FLOW ( N Engl J Med , 2024). Please read it before posting;…
NPFSMLAJS+16 20 22k 13mo

Related topics — sharing the tags heterogeneity, effect size, publication bias

TopicParticipantsRepliesViewsActivity
Regression to the mean in progress reports
On the subject in the title: Regression to the mean in progress reports Working notes rather than a conclusion. Session topic: PIONEER 6 ( N Engl J Med , 2019). Please read it before posting; the discussion…
HAAMTFAVDM+30 34 49k 12mo
[2026 update] Journal club: is percentage weight change the right endpoint?
Journal club: is percentage weight change the right endpoint? — that is the question, and I have not found it answered plainly anywhere I have looked. Comparing SURPASS-2 ( N Engl J Med , 2021) with…
MLSCNHHRS+105 118 18k 11mo
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just differently reported?
Tirzepatide and nausea: is the profile genuinely different or just differently reported? I have a specific reason for asking rather than idle curiosity, and the context is below. Comparing STEP 1 ( N Engl J…
BNNSKFCBP+109 122 3.6k 2mo
Comparing the STEP programme populations: who was actually enrolled
Comparing the STEP programme populations: who was actually enrolled Writing it up because I had to work it out twice and would rather nobody else did. Comparing STEP 1 ( N Engl J Med , 2021) with FLOW ( N…
LVBPNN 2 7.5k 2mo
Journal club: how we handle discontinuation in obesity trials — what changed since
Journal club: how we handle discontinuation in obesity trials — what changed since — setting out what I have, and where I think it stops being reliable. Session topic: STEP 4 ( JAMA , 2021). Please read it…
OVFVIISLJB+14 18 35k 8mo